Since the #pandemic, our doctors have remained vigilant in diagnosing and treating patients for #longCOVID. Pediatric allergist and immunologist Nathan Rabinovitch, MD, comments on the common symptoms of this persistent illness in this story by FOX31 KDVR / Channel 2 KWGN. https://brnw.ch/21wRvx4
关于我们
For more than 125 years, National Jewish Health has been at the forefront of research and medicine. We integrate the latest scientific discoveries with coordinated care for pulmonary, cardiac, immune and related conditions. National Jewish Health physicians and researchers are at the forefront of a new era in health care that embraces a personalized, preventive approach to medicine. We understand that each person is unique, and their variations in diet, environment, personal habits and DNA all influence their individual health. That is why two different people are exposed to certain conditions and only one gets sick and why certain treatments may work for one person and not for another. With a focus on personalized medicine, our researchers are looking at environment-gene interaction and making strides in predicting, preventing, treating and tracking many diseases. This proactive approach to medicine means that if you have a disease, or the probability of getting a disease, it may be detected sooner so that you may live longer, healthier and with a better quality of life. Our research is truly transforming the lives of millions. By using an individual's DNA to predict and prevent disease, to guide the right choice of therapy to limit side effects and bring higher success rates for treatments and to be able to track the effects of these therapies, National Jewish Health is working to improve health care for the future.
- 网站
-
https://www.njhealth.org
National Jewish Health的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 1,001-5,000 人
- 总部
- Denver，CO - Colorado
- 类型
- 非营利机构
- 创立
- 1899
- 领域
- Pulmonary、Rheumatology、Allergies & Immunology、Pediatrics、Gastroenterology和Cardiology
地点
-
主要
获取路线
1400 Jackson St
US，CO - Colorado，Denver，80206
National Jewish Health员工
动态
-
Announcing the 21st Annual Respiratory Disease Young Investigators' Forum October 9-12, 2025 in Denver, CO This unique educational opportunity is designed for pulmonary, allergy and immunology fellows and junior faculty who are in their first few years in an academic role. Thirty young investigators whose Basic Science Research or Clinical Research abstracts are selected will be invited to present their research at the Forum where a panel of expert faculty will evaluate their presentations and score them on specified criteria. Selected winners will be awarded a monetary prize to support their future research endeavors in respiratory medicine. Throughout the Forum, attendees will enjoy opportunities to meet and interact with expert faculty and peer researchers. Abstract Submission Deadline — Monday, June 16, 2025, 11:59 PM (PDT). Abstract Notification — Presenters will be notified via email of abstract status in July 2025. For more information about this opportunity and to submit your research abstract, visit https://brnw.ch/21wRsFd #MedicalFellows #EarlyCareer #PhysicianScientist #MedicalResearch #Basic Science #ClinicalResearch #MedicalConference #Meducation #Pulmonolgy #COVID #Asthma #COPD #ILD #LungDisease #SleepDisorder #Bronchiectasis
-
-
The number of #stemcell clinics has erupted over the last few years. However, the industry's lack of oversight in some foreign countries is giving experts pause. “If it sounds too good to be true, it is,” said Charles Daley, MD, chief of the Division of Mycobacterial and Respiratory Infections. Earlier last year, Dr. Daley treated patients who were infected with highly #drugresistant bacteria after receiving stem cell #therapy in Mexico. Learn more about this trend in this feature story by Men's Health. https://brnw.ch/21wRnT0
-
Five years after Colorado became one of the states with the most #COVID cases per capita, doctors are keeping a close watch on new threats, such as #birdflu and #measles outbreaks. Pulmonologist Ken Lyn-Kew, MD, explains the potential for virus mutation in this story by Colorado Public Radio. https://brnw.ch/21wRld6
-
Join Dr. Andrew Freeman for an innovative, two-day educational hybrid conference that redefines what you know about preventing and treating cardiovascular disease. Attendees of this multidisciplinary conference will gain cutting-edge insights into the latest advancements in cardiovascular disease prevention and treatment. Participants will explore new and emerging therapeutic options, including novel lipid-lowering agents, anti-inflammatory approaches, and breakthrough genetic interventions, all with the potential to transform patient care. This program is endorsed by the American Society for Preventive Cardiology (ASPC). The conference will also spotlight innovative technologies, such as advanced imaging, AI-driven diagnostics, and wearable health monitoring, equipping clinicians with the tools to enhance early detection and personalize treatment strategies. Attend in person at the National Jewish Health campus or online June 12-13 and be part of this transformative conversation on the future of cardiovascular health. Early bird registration is open now at https://brnw.ch/21wRiPc #Cardiology #Pulmonary #RenalDisease #Nursing #CardiovascularDisease #HeartDisease #MedicalConference #Healthcare #Nutrition #Lifestyle #Exercise #Nursing #PreventiveCardiology #MedicalConference #CME #MOC #CNE
-
-
Join Dr. Jennifer Taylor-Cousar, Dr. Jared Eddy, and nurse Sara Dederman-Brayshaw, to learn why diagnoses of cystic fibrosis continue to be missed both in infancy and later into adolescence and adulthood, and how health professionals can improve their ability to spot CF in patients to improve care. Missed or delayed diagnoses of CF and CFTR-related disorders can have important implications for disease progression and health outcomes. Participants in this program will increase their awareness about missed diagnoses of CF, examine factors that lead to missed diagnoses including race, rare mutations and pancreatic sufficiency, and analyze options for patient testing and treatment of suspected CF and CFTR-related disorders. 1.0 CME/CNE earned for completing this free course ending 3/29. https://brnw.ch/21wRhlY #MedicalEducation #CF #CysticFibrosis #CFTR #InfectiousDisease #PrimaryCare #Nursing #Pulmonology
-
-
Join us April 2-4 for the 61st Annual Denver TB Course, the longest-running TB course in the country. This conference presents the latest updates by experts from National Jewish Health, treating tuberculosis patients since 1899. This hybrid event provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis. Join us in Denver or via zoom. Recordings will be available to registered attendees after the conference. Registration is open at https://brnw.ch/21wRfPU #TB #Tuberculosis #PatientCare #InfectiousDisease #Healthcare #PublicHealth #Pulmonology #Radiology #MedicalConference #CME #CE
-
-
The #wildfires in North Carolina are causing a haze and a smoky smell to fill the air throughout the region. When is it okay for people to walk outside? Pulmonologist David Beuther, MD, details the measures you can take to protect your #lungs from poor #airquality in this story by ABC11 WTVD-TV. https://brnw.ch/21wRecF
-
Air pollution doesn't just affect the #lungs. New research shows that poor air quality can cause plaque to build up in artery walls, increasing the risks for #heart disease. Cardiologist Andrew Freeman, MD, and pulmonologist Lisa Maier, MD, discuss the heart and lung connection and the effects of #airpollution in this story by Your Hometown Lima Stations. https://brnw.ch/21wR5aV
-
Historically, people with eosinophilic granulomatosis with polyangiitis (#EGPA) had very limited #treatment options. However, according to pulmonologist Michael Wechsler, MD, new #biologic medications have led to "life-changing" results. Dr. Wechsler illuminates EGPA treatment options in this story for HealthCentral Corporation. https://brnw.ch/21wQYGp